Frontiers Production Office, Selected Research

Opipramol

1/2022

Erratum: Novel Opipramol-Baclofen Combination Alleviates Depression and Craving and Facilitates Recovery From Substance Use Disorder-An Animal Model and a Human Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frontiers Production Office, Research Topics

Disease

1	Substance-Related Disorders (Drug Abuse) 01/2022
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Sepsis (Septicemia) 01/2021
1	Cognitive Dysfunction 01/2021
1	COVID-19 01/2021
1	Ulcerative Colitis 01/2021
1	Migraine Disorders (Migraine) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

1	OpipramolIBA 01/2022
1	PBI-05204IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Baclofen FDA LinkGeneric 01/2022
1	Dextran SulfateIBA 01/2021
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021
1	4-phenylbutyric acid (Buphenyl)FDA Link 01/2021
1	ResveratrolIBA 01/2021
1	Mitochondrial Permeability Transition PoreIBA 01/2021
1	Nonprescription Drugs (Patent Medicines)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	erenumabIBA 01/2021
1	A-Form DNA (A-DNA)IBA 01/2020

Therapy/Procedure

1	Radiotherapy 01/2022
1	Acupuncture Therapy 01/2022